APO Research
Talk to an analyst

APO RESEARCH · REPORT

PDC Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global PDC Drugs Industry Growth and Trends Forecast to 2032

23 December 2025102 pages

Choose your research edition.

Industry ResearchPDC Drugs Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal PDC Drugs Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal PDC Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal PDC Drugs Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal PDC Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global PDC Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for PDC Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for PDC Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for PDC Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of PDC Drugs include Bicycle Therapeutics, Cybrexa Therapeutics, Theratechnologies, Beijing Shenogen Pharma Group, BrightGene Bio-Medical Technology, Gaorui Yaoye(Beijing)Technologies, Shanghai Huiyong Pharmaceutical, Shanghai Pharmaceuticals and Lumosa Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global PDC Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The PDC Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global PDC Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to PDC Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global PDC Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

PDC Drugs Market by Company

Bicycle Therapeutics

Cybrexa Therapeutics

Theratechnologies

Beijing Shenogen Pharma Group

BrightGene Bio-Medical Technology

Gaorui Yaoye(Beijing)Technologies

Shanghai Huiyong Pharmaceutical

Shanghai Pharmaceuticals

Lumosa Therapeutics

Tianjin Conjustar Biotechnology

XINOGEN (HONG KONG) PHARMA

Zhongshan Laibo Ruichen Biopharmaceutical

PDC Drugs Segment by Type

Cell-penetrating Peptides (CPP)

Cell Targeting Peptides (CTP)

Others

PDC Drugs Segment by Application

Breast Cancer

Pancreatic Cancer

Others

PDC Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PDC Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of PDC Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PDC Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of PDC Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of PDC Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Cell-penetrating Peptides (CPP) Table 2. Major Company of Cell Targeting Peptides (CTP) Table 3. Major Company of Others Table 4. Global PDC Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global PDC Drugs Sales by Type (2021-2026) & (k units) Table 6. Global PDC Drugs Sales Market Share in Volume by Type (2021-2026) Table 7. Global PDC Drugs Sales by Type (2021-2026) & (US$ Million) Table 8. Global PDC Drugs Sales Market Share in Value by Type (2021-2026) Table 9. Global PDC Drugs Price by Type (2021-2026) & (USD/unit) Table 10. Global PDC Drugs Sales by Type (2027-2032) & (k units) Table 11. Global PDC Drugs Sales Market Share in Volume by Type (2027-2032) Table 12. Global PDC Drugs Sales by Type (2027-2032) & (US$ Million) Table 13. Global PDC Drugs Sales Market Share in Value by Type (2027-2032) Table 14. Global PDC Drugs Price by Type (2027-2032) & (USD/unit) Table 15. North America PDC Drugs Sales by Type (2021-2026) & (k units) Table 16. North America PDC Drugs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe PDC Drugs Sales by Type (2021-2026) & (k units) Table 18. Europe PDC Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific PDC Drugs Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific PDC Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America PDC Drugs Sales by Type (2021-2026) & (k units) Table 22. Latin America PDC Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa PDC Drugs Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa PDC Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. PDC Drugs Industry Trends Table 26. PDC Drugs Industry Drivers Table 27. PDC Drugs Industry Opportunities and Challenges Table 28. PDC Drugs Industry Restraints Table 29. Global PDC Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global PDC Drugs Revenue Market Share by Company (2021-2026) Table 31. Global PDC Drugs Sales by Company (2021-2026) & (k units) Table 32. Global PDC Drugs Sales Share by Company (2021-2026) Table 33. Global PDC Drugs Market Price by Company (2021-2026) & (USD/unit) Table 34. Global PDC Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global PDC Drugs Major Company Production Sites and Headquarters Table 36. Global PDC Drugs Company, Product Type & Application Table 37. Global PDC Drugs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global PDC Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global PDC Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global PDC Drugs Sales by Region (2021-2026) & (k units) Table 42. Global PDC Drugs Sales Market Share in Volume by Region (2021-2026) Table 43. Global PDC Drugs Sales by Region (2021-2026) & (US$ Million) Table 44. Global PDC Drugs Sales Market Share in Value by Region (2021-2026) Table 45. Global PDC Drugs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Global PDC Drugs Sales by Region (2027-2032) & (k units) Table 47. Global PDC Drugs Sales Market Share in Volume by Region (2027-2032) Table 48. Global PDC Drugs Sales by Region (2027-2032) & (US$ Million) Table 49. Global PDC Drugs Sales Market Share in Value by Region (2027-2032) Table 50. Global PDC Drugs Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 51. Global PDC Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global PDC Drugs Sales by Application (2021-2026) & (k units) Table 53. Global PDC Drugs Sales Market Share in Volume by Application (2021-2026) Table 54. Global PDC Drugs Sales by Application (2021-2026) & (US$ Million) Table 55. Global PDC Drugs Sales Market Share in Value by Application (2021-2026) Table 56. Global PDC Drugs Price by Application (2021-2026) & (USD/unit) Table 57. Global PDC Drugs Sales by Application (2027-2032) & (k units) Table 58. Global PDC Drugs Sales Market Share in Volume by Application (2027-2032) Table 59. Global PDC Drugs Sales by Application (2027-2032) & (US$ Million) Table 60. Global PDC Drugs Sales Market Share in Value by Application (2027-2032) Table 61. Global PDC Drugs Price by Application (2027-2032) & (USD/unit) Table 62. North America PDC Drugs Sales by Application (2021-2026) & (k units) Table 63. North America PDC Drugs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe PDC Drugs Sales by Application (2021-2026) & (k units) Table 65. Europe PDC Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific PDC Drugs Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific PDC Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America PDC Drugs Sales by Application (2021-2026) & (k units) Table 69. Latin America PDC Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa PDC Drugs Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa PDC Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Bicycle Therapeutics Company Information Table 73. Bicycle Therapeutics Business Overview Table 74. Bicycle Therapeutics PDC Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. Bicycle Therapeutics PDC Drugs Product Portfolio Table 76. Bicycle Therapeutics Recent Development Table 77. Cybrexa Therapeutics Company Information Table 78. Cybrexa Therapeutics Business Overview Table 79. Cybrexa Therapeutics PDC Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. Cybrexa Therapeutics PDC Drugs Product Portfolio Table 81. Cybrexa Therapeutics Recent Development Table 82. Theratechnologies Company Information Table 83. Theratechnologies Business Overview Table 84. Theratechnologies PDC Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. Theratechnologies PDC Drugs Product Portfolio Table 86. Theratechnologies Recent Development Table 87. Beijing Shenogen Pharma Group Company Information Table 88. Beijing Shenogen Pharma Group Business Overview Table 89. Beijing Shenogen Pharma Group PDC Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Beijing Shenogen Pharma Group PDC Drugs Product Portfolio Table 91. Beijing Shenogen Pharma Group Recent Development Table 92. BrightGene Bio-Medical Technology Company Information Table 93. BrightGene Bio-Medical Technology Business Overview Table 94. BrightGene Bio-Medical Technology PDC Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. BrightGene Bio-Medical Technology PDC Drugs Product Portfolio Table 96. BrightGene Bio-Medical Technology Recent Development Table 97. Gaorui Yaoye(Beijing)Technologies Company Information Table 98. Gaorui Yaoye(Beijing)Technologies Business Overview Table 99. Gaorui Yaoye(Beijing)Technologies PDC Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Gaorui Yaoye(Beijing)Technologies PDC Drugs Product Portfolio Table 101. Gaorui Yaoye(Beijing)Technologies Recent Development Table 102. Shanghai Huiyong Pharmaceutical Company Information Table 103. Shanghai Huiyong Pharmaceutical Business Overview Table 104. Shanghai Huiyong Pharmaceutical PDC Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Shanghai Huiyong Pharmaceutical PDC Drugs Product Portfolio Table 106. Shanghai Huiyong Pharmaceutical Recent Development Table 107. Shanghai Pharmaceuticals Company Information Table 108. Shanghai Pharmaceuticals Business Overview Table 109. Shanghai Pharmaceuticals PDC Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Shanghai Pharmaceuticals PDC Drugs Product Portfolio Table 111. Shanghai Pharmaceuticals Recent Development Table 112. Lumosa Therapeutics Company Information Table 113. Lumosa Therapeutics Business Overview Table 114. Lumosa Therapeutics PDC Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Lumosa Therapeutics PDC Drugs Product Portfolio Table 116. Lumosa Therapeutics Recent Development Table 117. Tianjin Conjustar Biotechnology Company Information Table 118. Tianjin Conjustar Biotechnology Business Overview Table 119. Tianjin Conjustar Biotechnology PDC Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Tianjin Conjustar Biotechnology PDC Drugs Product Portfolio Table 121. Tianjin Conjustar Biotechnology Recent Development Table 122. XINOGEN (HONG KONG) PHARMA Company Information Table 123. XINOGEN (HONG KONG) PHARMA Business Overview Table 124. XINOGEN (HONG KONG) PHARMA PDC Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. XINOGEN (HONG KONG) PHARMA PDC Drugs Product Portfolio Table 126. XINOGEN (HONG KONG) PHARMA Recent Development Table 127. Zhongshan Laibo Ruichen Biopharmaceutical Company Information Table 128. Zhongshan Laibo Ruichen Biopharmaceutical Business Overview Table 129. Zhongshan Laibo Ruichen Biopharmaceutical PDC Drugs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Zhongshan Laibo Ruichen Biopharmaceutical PDC Drugs Product Portfolio Table 131. Zhongshan Laibo Ruichen Biopharmaceutical Recent Development Table 132. North America PDC Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 133. North America PDC Drugs Sales by Country (2021-2026) & (k units) Table 134. North America PDC Drugs Sales Market Share by Country (2021-2026) Table 135. North America PDC Drugs Sales Forecast by Country (2027-2032) & (k units) Table 136. North America PDC Drugs Sales Market Share Forecast by Country (2027-2032) Table 137. North America PDC Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. North America PDC Drugs Market Size by Country (2021-2026) & (US$ Million) Table 139. North America PDC Drugs Market Share by Country (2021-2026) Table 140. North America PDC Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. North America PDC Drugs Market Share Forecast by Country (2027-2032) Table 142. Europe PDC Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 143. Europe PDC Drugs Sales by Country (2021-2026) & (k units) Table 144. Europe PDC Drugs Sales Market Share by Country (2021-2026) Table 145. Europe PDC Drugs Sales Forecast by Country (2027-2032) & (k units) Table 146. Europe PDC Drugs Sales Market Share Forecast by Country (2027-2032) Table 147. Europe PDC Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Europe PDC Drugs Market Size by Country (2021-2026) & (US$ Million) Table 149. Europe PDC Drugs Market Share by Country (2021-2026) Table 150. Europe PDC Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Europe PDC Drugs Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific PDC Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific PDC Drugs Sales by Country (2021-2026) & (k units) Table 154. Asia-Pacific PDC Drugs Sales Market Share by Country (2021-2026) Table 155. Asia-Pacific PDC Drugs Sales Forecast by Country (2027-2032) & (k units) Table 156. Asia-Pacific PDC Drugs Sales Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific PDC Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific PDC Drugs Market Size by Country (2021-2026) & (US$ Million) Table 159. Asia-Pacific PDC Drugs Market Share by Country (2021-2026) Table 160. Asia-Pacific PDC Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Asia-Pacific PDC Drugs Market Share Forecast by Country (2027-2032) Table 162. Latin America PDC Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 163. Latin America PDC Drugs Sales by Country (2021-2026) & (k units) Table 164. Latin America PDC Drugs Sales Market Share by Country (2021-2026) Table 165. Latin America PDC Drugs Sales Forecast by Country (2027-2032) & (k units) Table 166. Latin America PDC Drugs Sales Market Share Forecast by Country (2027-2032) Table 167. Latin America PDC Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Latin America PDC Drugs Market Size by Country (2021-2026) & (US$ Million) Table 169. Latin America PDC Drugs Market Share by Country (2021-2026) Table 170. Latin America PDC Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Latin America PDC Drugs Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa PDC Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa PDC Drugs Sales by Country (2021-2026) & (k units) Table 174. Middle East and Africa PDC Drugs Sales Market Share by Country (2021-2026) Table 175. Middle East and Africa PDC Drugs Sales Forecast by Country (2027-2032) & (k units) Table 176. Middle East and Africa PDC Drugs Sales Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa PDC Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa PDC Drugs Market Size by Country (2021-2026) & (US$ Million) Table 179. Middle East and Africa PDC Drugs Market Share by Country (2021-2026) Table 180. Middle East and Africa PDC Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Middle East and Africa PDC Drugs Market Share Forecast by Country (2027-2032) Table 182. Key Raw Materials Table 183. Raw Materials Key Suppliers Table 184. PDC Drugs Distributors List Table 185. PDC Drugs Customers List Table 186. Research Programs/Design for This Report Table 187. Authors List of This Report Table 188. Secondary Sources Table 189. Primary Sources List of Figures Figure 1. PDC Drugs Image Figure 2. Global PDC Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global PDC Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global PDC Drugs Sales (2021-2032) & (k units) Figure 5. Cell-penetrating Peptides (CPP) Image Figure 6. Global Cell-penetrating Peptides (CPP) Sales YoY Growth (2021-2032) & (k units) Figure 7. Cell Targeting Peptides (CTP) Image Figure 8. Global Cell Targeting Peptides (CTP) Sales YoY Growth (2021-2032) & (k units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 11. Global PDC Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global PDC Drugs Market Share by Type 2025 VS 2032 Figure 13. North America PDC Drugs Sales Market Share in Volume by Type in 2025 Figure 14. North America PDC Drugs Sales Market Share in Value by Type in 2025 Figure 15. Europe PDC Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Europe PDC Drugs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific PDC Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific PDC Drugs Sales Market Share in Value by Type in 2025 Figure 19. Latin America PDC Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America PDC Drugs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa PDC Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa PDC Drugs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 PDC Drugs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Breast Cancer Image Figure 26. Global Breast Cancer Sales YoY Growth (2021-2032) & (k units) Figure 27. Pancreatic Cancer Image Figure 28. Global Pancreatic Cancer Sales YoY Growth (2021-2032) & (k units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 31. Global PDC Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global PDC Drugs Market Share by Application 2025 VS 2032 Figure 33. North America PDC Drugs Sales Market Share in Volume by Application in 2025 Figure 34. North America PDC Drugs Sales Market Share in Value by Application in 2025 Figure 35. Europe PDC Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Europe PDC Drugs Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific PDC Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific PDC Drugs Sales Market Share in Value by Application in 2025 Figure 39. Latin America PDC Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Latin America PDC Drugs Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa PDC Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa PDC Drugs Sales Market Share in Value by Application in 2025 Figure 43. North America PDC Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America PDC Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America PDC Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America PDC Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe PDC Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe PDC Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe PDC Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe PDC Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific PDC Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific PDC Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific PDC Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific PDC Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America PDC Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America PDC Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America PDC Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America PDC Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa PDC Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa PDC Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa PDC Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa PDC Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. PDC Drugs Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. PDC Drugs Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Cell-penetrating Peptides (CPP)
  • Cell Targeting Peptides (CTP)
  • Others
Applications
  • Breast Cancer
  • Pancreatic Cancer
  • Others
Companies covered
  • Bicycle Therapeutics
  • Cybrexa Therapeutics
  • Theratechnologies
  • Beijing Shenogen Pharma Group
  • BrightGene Bio-Medical Technology
  • Gaorui Yaoye(Beijing)Technologies
  • Shanghai Huiyong Pharmaceutical
  • Shanghai Pharmaceuticals
  • Lumosa Therapeutics
  • Tianjin Conjustar Biotechnology
  • XINOGEN (HONG KONG) PHARMA
  • Zhongshan Laibo Ruichen Biopharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global PDC Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global PDC Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 PDC Drugs Market by Type
  6. 1.3.1 Cell-penetrating Peptides (CPP)
  7. 1.3.2 Cell Targeting Peptides (CTP)
  8. 1.3.3 Others
  9. 1.4 Global PDC Drugs Market Size by Type
  10. 1.4.1 Global PDC Drugs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global PDC Drugs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global PDC Drugs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America PDC Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe PDC Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific PDC Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America PDC Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa PDC Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 PDC Drugs Industry Trends
  2. 2.2 PDC Drugs Industry Drivers
  3. 2.3 PDC Drugs Industry Opportunities and Challenges
  4. 2.4 PDC Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by PDC Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by PDC Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by PDC Drugs Price (2021-2026)
  4. 3.4 Global PDC Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global PDC Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global PDC Drugs Company, Product Type & Application
  7. 3.7 Global PDC Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global PDC Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 PDC Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 PDC Drugs Tier 1, Tier 2, and Tier 3
4 PDC Drugs Regional Status and Outlook
  1. 4.1 Global PDC Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global PDC Drugs Historic Market Size by Region
  3. 4.2.1 Global PDC Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global PDC Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global PDC Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global PDC Drugs Forecasted Market Size by Region
  7. 4.3.1 Global PDC Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global PDC Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global PDC Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 PDC Drugs by Application
  1. 5.1 PDC Drugs Market by Application
  2. 5.1.1 Breast Cancer
  3. 5.1.2 Pancreatic Cancer
  4. 5.1.3 Others
  5. 5.2 Global PDC Drugs Market Size by Application
  6. 5.2.1 Global PDC Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global PDC Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global PDC Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America PDC Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe PDC Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific PDC Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America PDC Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa PDC Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bicycle Therapeutics
  2. 6.1.1 Bicycle Therapeutics Company Information
  3. 6.1.2 Bicycle Therapeutics Business Overview
  4. 6.1.3 Bicycle Therapeutics PDC Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bicycle Therapeutics PDC Drugs Product Portfolio
  6. 6.1.5 Bicycle Therapeutics Recent Developments
  7. 6.2 Cybrexa Therapeutics
  8. 6.2.1 Cybrexa Therapeutics Company Information
  9. 6.2.2 Cybrexa Therapeutics Business Overview
  10. 6.2.3 Cybrexa Therapeutics PDC Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Cybrexa Therapeutics PDC Drugs Product Portfolio
  12. 6.2.5 Cybrexa Therapeutics Recent Developments
  13. 6.3 Theratechnologies
  14. 6.3.1 Theratechnologies Company Information
  15. 6.3.2 Theratechnologies Business Overview
  16. 6.3.3 Theratechnologies PDC Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Theratechnologies PDC Drugs Product Portfolio
  18. 6.3.5 Theratechnologies Recent Developments
  19. 6.4 Beijing Shenogen Pharma Group
  20. 6.4.1 Beijing Shenogen Pharma Group Company Information
  21. 6.4.2 Beijing Shenogen Pharma Group Business Overview
  22. 6.4.3 Beijing Shenogen Pharma Group PDC Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Beijing Shenogen Pharma Group PDC Drugs Product Portfolio
  24. 6.4.5 Beijing Shenogen Pharma Group Recent Developments
  25. 6.5 BrightGene Bio-Medical Technology
  26. 6.5.1 BrightGene Bio-Medical Technology Company Information
  27. 6.5.2 BrightGene Bio-Medical Technology Business Overview
  28. 6.5.3 BrightGene Bio-Medical Technology PDC Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 BrightGene Bio-Medical Technology PDC Drugs Product Portfolio
  30. 6.5.5 BrightGene Bio-Medical Technology Recent Developments
  31. 6.6 Gaorui Yaoye(Beijing)Technologies
  32. 6.6.1 Gaorui Yaoye(Beijing)Technologies Company Information
  33. 6.6.2 Gaorui Yaoye(Beijing)Technologies Business Overview
  34. 6.6.3 Gaorui Yaoye(Beijing)Technologies PDC Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Gaorui Yaoye(Beijing)Technologies PDC Drugs Product Portfolio
  36. 6.6.5 Gaorui Yaoye(Beijing)Technologies Recent Developments
  37. 6.7 Shanghai Huiyong Pharmaceutical
  38. 6.7.1 Shanghai Huiyong Pharmaceutical Company Information
  39. 6.7.2 Shanghai Huiyong Pharmaceutical Business Overview
  40. 6.7.3 Shanghai Huiyong Pharmaceutical PDC Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Shanghai Huiyong Pharmaceutical PDC Drugs Product Portfolio
  42. 6.7.5 Shanghai Huiyong Pharmaceutical Recent Developments
  43. 6.8 Shanghai Pharmaceuticals
  44. 6.8.1 Shanghai Pharmaceuticals Company Information
  45. 6.8.2 Shanghai Pharmaceuticals Business Overview
  46. 6.8.3 Shanghai Pharmaceuticals PDC Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Shanghai Pharmaceuticals PDC Drugs Product Portfolio
  48. 6.8.5 Shanghai Pharmaceuticals Recent Developments
  49. 6.9 Lumosa Therapeutics
  50. 6.9.1 Lumosa Therapeutics Company Information
  51. 6.9.2 Lumosa Therapeutics Business Overview
  52. 6.9.3 Lumosa Therapeutics PDC Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Lumosa Therapeutics PDC Drugs Product Portfolio
  54. 6.9.5 Lumosa Therapeutics Recent Developments
  55. 6.10 Tianjin Conjustar Biotechnology
  56. 6.10.1 Tianjin Conjustar Biotechnology Company Information
  57. 6.10.2 Tianjin Conjustar Biotechnology Business Overview
  58. 6.10.3 Tianjin Conjustar Biotechnology PDC Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Tianjin Conjustar Biotechnology PDC Drugs Product Portfolio
  60. 6.10.5 Tianjin Conjustar Biotechnology Recent Developments
  61. 6.11 XINOGEN (HONG KONG) PHARMA
  62. 6.11.1 XINOGEN (HONG KONG) PHARMA Company Information
  63. 6.11.2 XINOGEN (HONG KONG) PHARMA Business Overview
  64. 6.11.3 XINOGEN (HONG KONG) PHARMA PDC Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 XINOGEN (HONG KONG) PHARMA PDC Drugs Product Portfolio
  66. 6.11.5 XINOGEN (HONG KONG) PHARMA Recent Developments
  67. 6.12 Zhongshan Laibo Ruichen Biopharmaceutical
  68. 6.12.1 Zhongshan Laibo Ruichen Biopharmaceutical Company Information
  69. 6.12.2 Zhongshan Laibo Ruichen Biopharmaceutical Business Overview
  70. 6.12.3 Zhongshan Laibo Ruichen Biopharmaceutical PDC Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Zhongshan Laibo Ruichen Biopharmaceutical PDC Drugs Product Portfolio
  72. 6.12.5 Zhongshan Laibo Ruichen Biopharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America PDC Drugs Sales by Country
  2. 7.1.1 North America PDC Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America PDC Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America PDC Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America PDC Drugs Market Size by Country
  6. 7.2.1 North America PDC Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America PDC Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America PDC Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe PDC Drugs Sales by Country
  2. 8.1.1 Europe PDC Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe PDC Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe PDC Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe PDC Drugs Market Size by Country
  6. 8.2.1 Europe PDC Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe PDC Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe PDC Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific PDC Drugs Sales by Country
  2. 9.1.1 Asia-Pacific PDC Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific PDC Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific PDC Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific PDC Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific PDC Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific PDC Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific PDC Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America PDC Drugs Sales by Country
  2. 10.1.1 South America PDC Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America PDC Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America PDC Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America PDC Drugs Market Size by Country
  6. 10.2.1 South America PDC Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America PDC Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America PDC Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa PDC Drugs Sales by Country
  2. 11.1.1 Middle East and Africa PDC Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa PDC Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa PDC Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa PDC Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa PDC Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa PDC Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa PDC Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 PDC Drugs Value Chain Analysis
  2. 12.1.1 PDC Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 PDC Drugs Production Mode & Process
  7. 12.2 PDC Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 PDC Drugs Distributors
  10. 12.2.3 PDC Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst